Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

A new study suggests that a pill used for emergency contraception could be repurposed at a higher dose as an abortion drug, ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The fitness and lifestyle company also provided an optimistic outlook for fiscal 2025, further fueling the positive market response. Life Time's preliminary results for the fourth quarter show an ...

The company also provided fiscal 2025 revenue outlook above view. Life Time Group expects net income in the range of $31 million - $33 million for the fourth quarter, up from $23.7 million ...

The fitness and lifestyle company also provided an optimistic outlook for fiscal 2025, further fueling the positive market response. Life Time's preliminary results for the fourth quarter show an ...

AM Best has maintained a stable outlook on India’s non-life insurance segment, owing to robust growth potential, driven by regulatory initiatives and rising insurance demand. The report also ...

A lesser-known chapter of Bose’s life involves his travels across Europe in the late 1930s. His interactions with leaders like Benito Mussolini in Italy and attempts to seek support from Adolf ...